feed,title,long_url,short_url
Benzinga,"Sickle Cell Disease Treatment Market to Exhibit a CAGR of 18.5% and Reach USD 7.71 Billion by 2027; FDA Approval for Emmaus's Endari to Aid Development, states Fortune Business Insightsâ„¢",https://www.benzinga.com/pressreleases/21/01/g19234054/sickle-cell-disease-treatment-market-to-exhibit-a-cagr-of-18-5-and-reach-usd-7-71-billion-by-2027-,https://j.mp/391kLq0
